Role of Diacylglycerol Activation of PKCθ in Lipid-induced Muscle Insulin Resistance in Humans

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2014 Jul 1

PMID 24979806

Citations 182

Authors

Julia Szendroedi

Toru Yoshimura

Esther Phielix

Chrysi Koliaki

Mellissa Marcucci

Dongyan Zhang

Tomas Jelenik

Janette Muller

Christian Herder

Peter Nowotny

Gerald I Shulman

Michael Roden

Affiliations

Soon will be listed here.

Abstract

Muscle insulin resistance is a key feature of obesity and type 2 diabetes and is strongly associated with increased intramyocellular lipid content and inflammation. However, the cellular and molecular mechanisms responsible for causing muscle insulin resistance in humans are still unclear. To address this question, we performed serial muscle biopsies in healthy, lean subjects before and during a lipid infusion to induce acute muscle insulin resistance and assessed lipid and inflammatory parameters that have been previously implicated in causing muscle insulin resistance. We found that acute induction of muscle insulin resistance was associated with a transient increase in total and cytosolic diacylglycerol (DAG) content that was temporally associated with protein kinase (PKC)θ activation, increased insulin receptor substrate (IRS)-1 serine 1101 phosphorylation, and inhibition of insulin-stimulated IRS-1 tyrosine phosphorylation and AKT2 phosphorylation. In contrast, there were no associations between insulin resistance and alterations in muscle ceramide, acylcarnitine content, or adipocytokines (interleukin-6, adiponectin, retinol-binding protein 4) or soluble intercellular adhesion molecule-1. Similar associations between muscle DAG content, PKCθ activation, and muscle insulin resistance were observed in healthy insulin-resistant obese subjects and obese type 2 diabetic subjects. Taken together, these data support a key role for DAG activation of PKCθ in the pathogenesis of lipid-induced muscle insulin resistance in obese and type 2 diabetic individuals.

Citing Articles

Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: Myocellular mechanisms involved.

Castillo I, Argiles J, Rueda R, Ramirez M, Pedrosa J Rev Endocr Metab Disord. 2025; .

PMID: 40064750 DOI: 10.1007/s11154-025-09954-9.

Multi-tissue metabolomics reveal mtDNA- and diet-specific metabolite profiles in a mouse model of cardiometabolic disease.

Shastry A, Wilkinson M, Miller D, Kuriakose M, Veeneman J, Smith M Redox Biol. 2025; 81:103541.

PMID: 39983345 PMC: 11893332. DOI: 10.1016/j.redox.2025.103541.

Mechanistic Insights Into the Exercise-Induced Changes in Muscle Lipids and Insulin Sensitivity-Expanding on the "Athlete's Paradox": Revisiting a 2011 Diabetes Classic by Amati et al.

Horowitz J, Goodpaster B Diabetes. 2025; 74(2):134-137.

PMID: 39836884 PMC: 11755679. DOI: 10.2337/dbi24-0030.

Determinants of increased muscle insulin sensitivity of exercise-trained versus sedentary normal weight and overweight individuals.

Pesta D, Anadol-Schmitz E, Sarabhai T, Op den Kamp Y, Gancheva S, Trinks N Sci Adv. 2025; 11(1):eadr8849.

PMID: 39742483 PMC: 11691647. DOI: 10.1126/sciadv.adr8849.

Reducing the mitochondrial oxidative burden alleviates lipid-induced muscle insulin resistance in humans.

Fiorenza M, Onslev J, Henriquez-Olguin C, Persson K, Hesselager S, Jensen T Sci Adv. 2024; 10(44):eadq4461.

PMID: 39475607 PMC: 11524190. DOI: 10.1126/sciadv.adq4461.

References

Kumashiro N, Erion D, Zhang D, Kahn M, Beddow S, Chu X . Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci U S A. 2011; 108(39):16381-5. PMC: 3182681. DOI: 10.1073/pnas.1113359108. View

Mihalik S, Goodpaster B, Kelley D, Chace D, Vockley J, Toledo F . Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring). 2010; 18(9):1695-700. PMC: 3984458. DOI: 10.1038/oby.2009.510. View

Borkman M, Storlien L, Pan D, Jenkins A, Chisholm D, Campbell L . The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med. 1993; 328(4):238-44. DOI: 10.1056/NEJM199301283280404. View

Bergman B, Hunerdosse D, Kerege A, Playdon M, Perreault L . Localisation and composition of skeletal muscle diacylglycerol predicts insulin resistance in humans. Diabetologia. 2012; 55(4):1140-50. PMC: 3296871. DOI: 10.1007/s00125-011-2419-7. View

Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Furnsinn C . Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes. 1999; 48(2):358-64. DOI: 10.2337/diabetes.48.2.358. View

Coen P, Dube J, Amati F, Stefanovic-Racic M, Ferrell R, Toledo F . Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes. 2009; 59(1):80-8. PMC: 2797948. DOI: 10.2337/db09-0988. View

Brehm A, Krssak M, Schmid A, Nowotny P, Waldhausl W, Roden M . Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes. 2005; 55(1):136-40. View

Jensen M, Caruso M, Heiling V, Miles J . Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes. 1989; 38(12):1595-601. DOI: 10.2337/diab.38.12.1595. View

Storgaard H, Jensen C, Bjornholm M, Song X, Madsbad S, Zierath J . Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes. J Clin Endocrinol Metab. 2004; 89(3):1301-11. DOI: 10.1210/jc.2003-031243. View

10.

Yu C, Chen Y, Cline G, Zhang D, Zong H, Wang Y . Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 2002; 277(52):50230-6. DOI: 10.1074/jbc.M200958200. View

11.

Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R . Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes. 2005; 54(6):1640-8. DOI: 10.2337/diabetes.54.6.1640. View

12.

Boden G, Chen X, Ruiz J, White J, Rossetti L . Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest. 1994; 93(6):2438-46. PMC: 294452. DOI: 10.1172/JCI117252. View

13.

Weiss R, Dufour S, Taksali S, Tamborlane W, Petersen K, Bonadonna R . Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet. 2003; 362(9388):951-7. PMC: 2995523. DOI: 10.1016/S0140-6736(03)14364-4. View

14.

Straczkowski M, Kowalska I, Nikolajuk A, Dzienis-Straczkowska S, Kinalska I, Baranowski M . Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes. 2004; 53(5):1215-21. DOI: 10.2337/diabetes.53.5.1215. View

15.

Kado S, Nagata N . Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2000; 46(2):143-8. DOI: 10.1016/s0168-8227(99)00083-2. View

16.

Roden M, Price T, Perseghin G, Petersen K, Rothman D, Cline G . Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996; 97(12):2859-65. PMC: 507380. DOI: 10.1172/JCI118742. View

17.

Cline G, Petersen K, Krssak M, Shen J, Hundal R, Trajanoski Z . Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med. 1999; 341(4):240-6. DOI: 10.1056/NEJM199907223410404. View

18.

Glass C, Olefsky J . Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012; 15(5):635-45. PMC: 4156155. DOI: 10.1016/j.cmet.2012.04.001. View

19.

Randle P, Garland P, Hales C, Newsholme E . The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963; 1(7285):785-9. DOI: 10.1016/s0140-6736(63)91500-9. View

20.

Chavez J, Holland W, Bar J, Sandhoff K, Summers S . Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. J Biol Chem. 2005; 280(20):20148-53. DOI: 10.1074/jbc.M412769200. View